LONG-TERM OUTCOME OF TREATMENT WITH INFLIXIMAB IN PEDIATRIC CROHN’S DISEASE (CD). A POPULATION-BASED STUDY.

(1) Gastroenterology Unit, Hospital and University Lille

(2) Biostatistics, Univ Lille Nord de France, Lille

(3) Gastroenterology Unit, Hospital and University Rouen, Rouen

(4) Gastroenterology Unit, Hospital and University Amiens, Amiens

(5) Paediatric Unit

(6) Epidemiology Unit, Hospital and University Lille, Lille

(7) Gastroenterology Unit, St Louis Hospital, Paris, France



This item was part of the Changing the course of IBD: Is it applicable to all? session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A25